ArticleEuropean urology2015

Re: nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT.

Romain Mathieu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.